在超增强剂驱动的瘤发生过程中,液体-液体相分离:机制,免疫逃避和治疗影响
Ruoxi Yu1, Deyu Sun1, Chuang Zhang1
1Department of Radiotherapy Oncology, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital and Institute, Cancer Hospital of China Medical University, Shenyang, China.
Frontiers in cell and developmental biology
|December 1, 2025
概括
液-液相分离 (LLPS) 通过通过超级增强剂 (SE) 调节基因表达和免疫逃避来驱动癌症. 了解SE中的LLPS为癌症治疗提供了新的治疗策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
背景情况:
- 液-液相分离 (LLPS) 涉及生物分子通过弱相互作用形成无膜有机体.
- 在超级增强剂 (SE) 驱动的瘤发生,癌症进展和免疫逃避中,LLPS发挥着关键作用.
- SE是基因表达的关键调节元件,并与各种癌症有关.
研究的目的:
- 审查最近LLPS在SE驱动的瘤发生和免疫逃避中的作用的进展.
- 讨论针对LLPS在癌症治疗中的治疗潜力.
- 阐明LLPS调节瘤相关基因表达的机制.
主要方法:
- 关于癌症中LLPS和SE的最新研究的文献综述.
- 对链接LLPS,SE和基因调节的分子机制的分析.
- 检查LLPS在瘤微环境和免疫逃避中的作用.
主要成果:
- 通过促进转录因子招募,染色质循环和保持染色质可访问性,LLPS调节瘤相关基因表达.
- 与LLPS相关的SE影响瘤细胞和瘤微环境中的免疫细胞,促进免疫逃避.
- 在癌症发展的各个阶段,从发病到进展,LLPS都与此有关.
结论:
- 了解LLPS和SE之间的相互作用对于破译瘤启动和进展机制至关重要.
- 针对LLPS介导的过程,为新的抗癌治疗策略提供了一个有希望的途径.
- 在癌症中,LLPS是致癌过程和免疫逃避的关键调节者.
更多相关视频
相关概念视频
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Mechanisms of Retrovirus-induced Cancers
6.8K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.8K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K


